Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 2

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Neoplasms 2Glioma 2Recurrence 1Brain Stem Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 114Radiotherapy 99Bevacizumab 95Magnetic Resonance Spectroscopy 64Carboplatin 48Etoposide 34Surgical Procedures, Operative 33Irinotecan 33pembrolizumab 32Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 29Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × rindopepimut × Clear all
NCT01058850 2021-09-27

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

Stanford University

Phase 1 Terminated
3 enrolled
CNS

Brain Neoplasms, Brain Stem Neoplasms

NCT01498328 2020-02-17

ReACT

Celldex Therapeutics

Phase 2 Completed
127 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT01480479 2018-01-16

ACT IV

Celldex Therapeutics

Phase 3 Completed
745 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡